These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 3726289)

  • 1. Increased serum copper in pulmonary hypertension: involvement of thromboxane?
    Backon J
    Respiration; 1986; 50(1):72. PubMed ID: 3726289
    [No Abstract]   [Full Text] [Related]  

  • 2. Thromboxane-dependent portopulmonary hypertension.
    Maruyama T; Ohsaki K; Shimoda S; Kaji Y; Harada M
    Am J Med; 2005 Jan; 118(1):93-4. PubMed ID: 15639216
    [No Abstract]   [Full Text] [Related]  

  • 3. [Thromboxane A2-PGI2 balance and its clinical significance].
    Zhou YC; Wong XZ
    Zhonghua Nei Ke Za Zhi; 1987 Jan; 26(1):49-52. PubMed ID: 3297553
    [No Abstract]   [Full Text] [Related]  

  • 4. Thromboxane-mediated hypertension and vascular leakage evoked by low doses of Escherichia coli hemolysin in rabbit lungs.
    Seeger W; Walter H; Suttorp N; Muhly M; Bhakdi S
    J Clin Invest; 1989 Jul; 84(1):220-7. PubMed ID: 2500455
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An imbalance between the excretion of thromboxane and prostacyclin metabolites in pulmonary hypertension.
    Christman BW; McPherson CD; Newman JH; King GA; Bernard GR; Groves BM; Loyd JE
    N Engl J Med; 1992 Jul; 327(2):70-5. PubMed ID: 1603138
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Effects of thromboxane A2 on chronic hypoxic pulmonary hypertension in the rat].
    Saito M; Tatsumi K; Kasahara Y; Sugito K; Igari H; Tani T; Kuriyama T
    Nihon Kyobu Shikkan Gakkai Zasshi; 1996 Jan; 34(1):37-44. PubMed ID: 8717289
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative effects of beraprost, a stable analogue of prostacyclin, with PGE(1), nitroglycerin and nifedipine on canine model of vasoconstrictive pulmonary hypertension.
    Tamura M; Kurumatani H; Matsushita T
    Prostaglandins Leukot Essent Fatty Acids; 2001 Mar; 64(3):197-202. PubMed ID: 11334556
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased serum copper in primary pulmonary hypertension: a possible pathogenic link?
    Ahmed T; Sackner MA
    Respiration; 1985; 47(4):243-6. PubMed ID: 4012044
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effect of aspirin on pulmonary hypertension in rat during chronic hypoxia and hypercapnia].
    Zeng HH; Wang LX; Chen SX; Wang MS; Fan XF
    Zhongguo Ying Yong Sheng Li Xue Za Zhi; 2003 Nov; 19(4):319-22. PubMed ID: 21166220
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Leukotriene antagonists attenuate thromboxane-inducible pulmonary hypertension.
    Soifer SJ; Schreiber MD; Heymann MA
    Pediatr Res; 1989 Aug; 26(2):83-7. PubMed ID: 2505220
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effect of arachidonic acid metabolites on the lung].
    Sun QW
    Sheng Li Ke Xue Jin Zhan; 1986 Apr; 17(2):129-33. PubMed ID: 3538396
    [No Abstract]   [Full Text] [Related]  

  • 12. A study of aspirin and clopidogrel in idiopathic pulmonary arterial hypertension.
    Robbins IM; Kawut SM; Yung D; Reilly MP; Lloyd W; Cunningham G; Loscalzo J; Kimmel SE; Christman BW; Barst RJ
    Eur Respir J; 2006 Mar; 27(3):578-84. PubMed ID: 16507859
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of platelet-activating factor in pneumolysin-induced acute lung injury.
    Witzenrath M; Gutbier B; Owen JS; Schmeck B; Mitchell TJ; Mayer K; Thomas MJ; Ishii S; Rosseau S; Suttorp N; Schütte H
    Crit Care Med; 2007 Jul; 35(7):1756-62. PubMed ID: 17522574
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Systemic and pulmonary hypertension after abrupt cessation of prostacyclin: role of thromboxane A2.
    Cuiper LL; Price PV; Christman BW
    J Appl Physiol (1985); 1996 Jan; 80(1):191-7. PubMed ID: 8847301
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Thromboxane A2 metabolism and clinical effects of selective thromboxane A2 synthetase inhibitor in patients with chronic glomerulonephritis].
    Niwa T; Nomura T; Ozawa Y; Maeda K; Shibata M
    Nihon Jinzo Gakkai Shi; 1987 Jun; 29(6):655-65. PubMed ID: 3682335
    [No Abstract]   [Full Text] [Related]  

  • 16. Effects of dipyridamole infusion on local platelet aggregation and local formation of thromboxane A2 in patients with pulmonary hypertension.
    Gensini GF; Rostagno C; Pezza A; Fanara F; Castellani S; Prisco D; Rogasi PG; Boddi M; Neri Serneri GG
    Adv Prostaglandin Thromboxane Leukot Res; 1985; 13():257-62. PubMed ID: 3159209
    [No Abstract]   [Full Text] [Related]  

  • 17. Prevention of complement-induced pulmonary hypertension and improvement of right ventricular function by selective thromboxane receptor antagonism.
    Smith WJ; Murphy MP; Appleyard RF; Rizzo RJ; Aklog L; Laurence RG; Cohn LH
    J Thorac Cardiovasc Surg; 1994 Mar; 107(3):800-6. PubMed ID: 8127109
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of respiratory alkalosis on thromboxane-induced pulmonary hypertension in piglets.
    Redding GJ; Gibson RL; Davis CB; Truog WE
    Pediatr Res; 1988 Nov; 24(5):558-62. PubMed ID: 3205605
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Platelet-induced pulmonary hypertension and edema. A mechanism involving acetyl glyceryl ether phosphorylcholine and thromboxane A2.
    Heffner JE; Shoemaker SA; Canham EM; Patel M; McMurtry IF; Morris HG; Repine JE
    Chest; 1983 May; 83(5 Suppl):78S-79S. PubMed ID: 6839854
    [No Abstract]   [Full Text] [Related]  

  • 20. Protamine-induced pulmonary hypertension in heparinized monkeys and pigs is inhibited by the thromboxane receptor antagonist SQ 30,741.
    Schumacher WA; Heran CL; Ogletree ML
    Eicosanoids; 1990; 3(2):87-93. PubMed ID: 2144979
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.